+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Early Phase 1
Age: 18Years - 60Years
All Genders
ID05922306

Study Comparing Continuous and Pulsed PEG-Interferon Alpha-2b with Nucleostide Analogues in Treating Chronic Hepatitis B for 96 Weeks

Led by Anhui Medical University · Updated on 2023-06-28

1084

Participants Needed

1

Research Sites

26 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying chronic hepatitis B CHB patients to compare two ways of using pegylated interferon alpha-2b combined with nucleostide analogs NAs. The study aims to see which approachcontinuous or pulsed therapymore effectively achieves clinical cure and conversion of hepatitis B surface antigen HBsAg and e antigen. This large, multicenter, real-world study will also measure new markers of hepatitis B infection over time to better understand treatment effects. Participants will receive pegylated interferon alpha-2b injections of 180 micrograms subcutaneously once weekly. One group will get continuous treatment for up to 96 weeks, while the other group will follow a pulsed regimen of 8 weeks on treatment followed by 4 weeks off, repeated over 96 weeks. Both groups will continue NA therapy throughout. The study tracks changes in viral markers, including HBV pgRNA, HBcrAg, and anti-HBcAb, at multiple time points during the treatment. During the study, participants will be regularly assessed at baseline and weeks 12, 24, 48, 72, and 96. These assessments include laboratory tests measuring hepatitis B markers to evaluate treatment response, particularly HBsAg and HBsAb conversion rates after 96 weeks. Safety and clinical outcomes will be monitored throughout the study, which is expected to last up to 96 weeks per participant. This study seeks to provide insight into optimizing treatment strategies for CHB patients using interferon combined with NAs.

CONDITIONS

Brief Title

Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B

Research Team

Y

Yufeng Gao, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here